Central Depository Services (India) Limited

Downstream

Downstream are government hospitals, clinics and distributors in public-health schemes, which get cheaper patented drugs, while patent sellers lose sales.

Upstream

Upstream are ingredient and raw-material suppliers like Divi's Labs and Laurus Labs, which gain if generic copies need more active ingredients.

Business

Government health programmes may shift orders from costly patent sellers to approved generic makers; overall pill volumes stay similar, but who gets paid changes.

Capital

Investors turn cautious on patent-heavy sellers and look toward generic and ingredient makers that could win state orders.

Healthcare

Patent-holding sellers face price cuts while approved generic and ingredient makers gain order chances; hospitals see little direct change.

Immediate

In 1–7 days drug stocks wobble as investors reprice patent risk and generic hopes.

Medium term

In 1–6 months any first government authorisation to a generic maker sets prices and volumes.

Short term

In 1–4 weeks lawyers parse the judgment and government hints which drugs or schemes come first.

Downstream

No downstream change — Wipro clients buy IT projects and traders use BSE screens the same as before; only share ownership shifts.

Upstream

No upstream change — BSE suppliers like CDSL, which handles share accounts, and IRIS see no extra orders from an index inclusion.

Business

No new business demand — no company orders more stock-exchange trading or IT work just because the Nifty 50 list changed.

Capital

Strong capital reshuffle — Nifty 50 index funds and exchange-traded funds (ETFs) that copy the list must buy BSE and sell Wipro to mirror the new weights.

Financial Services

Mild positive mood for exchange and market-infrastructure names like MCX and CDSL on BSE's spotlight, but no real money flow beyond BSE itself.

Information Technology

Mild negative mood as Wipro's exit trims IT weight in Nifty, but no business hit to TCS, Infosys, HCLTech or other IT firms.

Immediate

Tomorrow into this week, BSE rises on forced index buying while Wipro slips on forced selling as funds adjust to the new list.

Medium term

Over 1-6 months, index effect disappears — BSE follows trading volumes and Wipro follows IT deals and margins.

Short term

Over 1-4 weeks, the pop and drop fade as short-term traders unwind bets and both stocks settle back toward business value.

Downstream

Brokers, traders and clearing members that route commodity orders through MCX gain more business as volumes and turnover climb toward Rs 3,220 lakh crore.

Upstream

CDSL, a depository that holds shares and settles trades for brokers, gains if MCX's client growth brings new demat accounts and settlements.

Business

MCX earns fees from each commodity trade, so 19% yearly sales growth means many more trades from its 2.1 million clients; BSE and CDSL see a lighter lift as overall market activity rises, while power trading at IEX stays separate.

Capital

Investors are likely to buy MCX on the strong outlook, with some spillover buying into BSE and CDSL as fellow market-infrastructure shares, while IEX sees little fresh flow.

Financial Services

Exchange and depository shares firm on the growth outlook, with no wider bank or insurer impact since the call is MCX-specific.

Immediate

Next 1-7 days: MCX shares firm on the 19% growth call; BSE and CDSL edge up on sympathy.

Medium term

Next 1-6 months: Quarterly results show whether 19% growth and 2.1 million clients are compounding as Macquarie expects.

Short term

Next 1-4 weeks: Traders watch MCX volumes and client adds to confirm the path toward Rs 3,220 lakh crore.

Downstream

Downstream, the stock exchange and the share depository pass services to retail brokers such as the Groww app, wealth managers such as Anand Rathi, fund transfer agents such as KFintech and CAMS, and the commodity futures exchange, which all serve the newly eligible wealthy investors.

Upstream

Upstream, there is no factory-style supply chain, but BSE Limited, which runs the stock exchange, relies on Central Depository Services, which keeps shares in electronic form, for settlement support and on IRIS, the software firm that supplies reporting tools to the exchange, so both should see slightly more processing work.

Business

More people and firms qualify as accredited investors, so demand rises for private funds, portfolio-management services and listed company bonds, which in turn means more stock-exchange trades, more electronic share accounts with the depository, more fund folios for transfer agents, and more client openings for retail brokers and wealth managers.

Capital

Investors are likely to bid up shares of market-infrastructure firms such as the stock exchange, the share depository, the commodity exchange, fund transfer agents and retail brokers, while money does not move toward insurers, banks or lenders on this news.

Financial Services

Positive for market-infrastructure and broker stocks as a wider accredited base should lift trading, account openings and fee income, while insurers, banks and lenders see little change.

Information Technology

Slightly positive for the small reporting-software supplier to the exchange, which should see a little more compliance and onboarding work.

Immediate

In the first week, shares of the stock exchange, the depository and brokers may see a small sentiment lift as traders price in higher volumes.

Medium term

Over the next few months, more company-bond listings and private-fund launches should build up, with the options-settlement plan helping clear old cases.

Short term

Over the next few weeks, brokers and wealth managers should start signing up newly eligible wealthy clients and adjust ads to the new common code.

Downstream

Downstream, wealth-management clients get wider investment choice, IPO sellers gain a new class of buyers, and commodity hedgers get deeper markets as foreign traders join.

Upstream

Exchange technology and service vendors such as CDSL (electronic shareholding records, a named supplier to both BSE and MCX) and IRIS (regulatory software, a named supplier to BSE) should see more usage as trading volumes rise.

Business

Wealth managers gain a bigger product shelf (IPOs, foreign shares, ETFs) to win client money; exchanges, brokers, depositories and record-keepers gain order and account volumes that turn into fee income.

Capital

Investors are likely to bid up exchange, broker, AMC and market-infrastructure shares on hopes of faster fee growth, while insurers, lenders and payments firms see no new money flow.

Financial Services

Positive for the capital-market corner (exchanges, brokers, wealth managers, AMCs, depositories, record-keepers) through higher volumes and fees; neutral for banks, lenders, insurers and payments firms, which get no flow from this rule change.

Immediate

1-7 days: exchange, broker and AMC shares react to the volume-growth story; insurers and lenders stay flat.

Medium term

1-6 months: actual growth in trading volumes, PMS money and ETF holdings shows whether the fee gains are real.

Short term

1-4 weeks: wealth managers announce new IPO-linked and foreign-investing products; foreign desks line up commodity access.